(Q42661119)

4 November 2017

title

Economic assessment of adjustable maintenance treatment with budesonide/formoterol in a single inhaler versus fixed treatment in asthma (English)

1 reference

4 November 2017

1 reference

budesonide/formoterol

1 reference

5

Claus Vogelmeier

1 reference

4 November 2017

8

Roland Buhl

1 reference

4 November 2017

Bernd Brüggenjürgen

1

1 reference

4 November 2017

Dagmar Selim

2

1 reference

4 November 2017

Peter Kardos

3

1 reference

4 November 2017

Kai Richter

4

1 reference

4 November 2017

Stephanie Roll

6

1 reference

4 November 2017

Wolfgang Meyer-Sabellek

7

1 reference

4 November 2017

Stefan N Willich

9

1 reference

4 November 2017

language of work or name

1 reference

1 January 2005

1 reference

4 November 2017

1 reference

4 November 2017

volume

23

1 reference

4 November 2017

issue

7

1 reference

4 November 2017

page(s)

723-731

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200523070-00006

4 November 2017

1 reference

Risk factors and costs associated with an asthma attack

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200523070-00006

The impact of exacerbations on the asthmatic patient's preference scores.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200523070-00006

Guided self management of asthma--how to do it

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200523070-00006

Self-management, autonomy, and quality of life in asthma. Population Medicine Group 91C.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200523070-00006

Self-management of asthma in general practice, asthma control and quality of life: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200523070-00006

Reductions in hospital use from self management training for chronic asthmatics.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200523070-00006

Is asthma self-management cost-effective?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200523070-00006

Randomised comparison of cost effectiveness of guided self management and traditional treatment of asthma in Finland.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200523070-00006

Randomized controlled economic evaluation of asthma self-management in primary health care

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200523070-00006

Measuring compliance with inhaled medication in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200523070-00006

Asthma: guided self management

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200523070-00006

The effect of adjustable dosing with budesonide/formoterol on health-related quality of life and asthma control compared with fixed dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200523070-00006

Validation of a standardized version of the Asthma Quality of Life Questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200523070-00006

Determining a minimal important change in a disease-specific Quality of Life Questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200523070-00006

Improvement in health-related quality of life with fluticasone propionate compared with budesonide or beclomethasone dipropionate in adults with severe asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200523070-00006

Reduction in oral corticosteroid use with mometasone furoate dry powder inhaler improves health-related quality of life in patients with severe persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200523070-00006

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200523070-00006

Pharmacoeconomic evaluation in the real world. Effectiveness versus efficacy studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200523070-00006

Adjustable maintenance dosing with budesonide/formoterol reduces asthma exacerbations compared with traditional fixed dosing: a five-month multicentre Canadian study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200523070-00006

Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200523070-00006

British guideline on the management of asthma

21 January 2018

1 reference

12 December 2020

Onset and duration of action of single doses of formoterol inhaled via Turbuhaler

1 reference

12 December 2020

Trends in the cost of illness for asthma in the United States, 1985-1994

1 reference

12 December 2020

Management of patients with asthma and COPD: monitoring quality of life and the relationship to subsequent GP interventions

1 reference

12 December 2020

A dose-response study with formoterol Turbuhaler as maintenance therapy in asthmatic patients

1 reference

12 December 2020

Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986

1 reference

12 December 2020

The common cold as a trigger of asthma

1 reference

12 December 2020

Action plans, self-monitoring and adherence: changing behaviour to promote better self-management.

1 reference

12 December 2020

Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma

1 reference

12 December 2020

Budesonide/formoterol adjustable maintenance dosing reduces asthma exacerbations versus fixed dosing.

1 reference

12 December 2020

The economic impact of asthma and chronic obstructive pulmonary disease (COPD) in Sweden in 1980 and 1991

1 reference

12 December 2020

[Epidemiology and costs of bronchial asthma and chronic bronchitis in Germany]

1 reference

12 December 2020

Asthma self-management programs can reduce the need for hospital-based asthma care

1 reference

12 December 2020

The effect of prescribed daily dose frequency on patient medication compliance

1 reference

12 December 2020

10.2165/00019053-200523070-00006

Identifiers

DOI

1 reference

Dimensions Publication ID

4 November 2017

1004166984

0 references

1 reference